Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda and Lynparza in advanced cervical cancer
NCT04483544Phase 2Terminated
- Sponsor
- Baptist Health South Florida
- Start
- Dec 2020
- Primary completion
- Dec 2024
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab, olaparib in Cervical Cancer (CC), sponsored by Baptist Health South Florida. Started Dec 2020; status: terminated.
02
Drugs
pembrolizumabolaparib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04483544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04483544.